ACTIVATED-CHARCOAL IN THE TREATMENT OF DRUG OVERDOSE - AN UPDATE

被引:12
作者
PALATNICK, W [1 ]
TENENBEIN, M [1 ]
机构
[1] UNIV MANITOBA,DEPT FAMILY MED,WINNIPEG R3T 2N2,MANITOBA,CANADA
关键词
D O I
10.2165/00002018-199207010-00002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:3 / 7
页数:5
相关论文
共 56 条
[1]  
Albertson T.E., Derlet R.W., Foulke G.E., Inguillon M.L., Tharratt S.R., Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions, Annals of Emergency Medicine, 18, pp. 56-59, (1989)
[2]  
Benson B., Van Antwerp M., Hergott T., A fatality resulting from multiple dose activated charcoal therapy, Veterinary and Human Toxicology, 31, (1989)
[3]  
Berg M.J., Berlinger W.G., Goldberg M.J., Spector R., Johnston G.F., Acceleration of body clearance of phenobarbital by oral activated charcoal, New England Journal of Medicine, 307, pp. 642-644, (1982)
[4]  
Berlinger W.G., Spector R., Goldberg M.J., Johnson G.E., Que C.K., Et al., Enhancement of theophylline clearance by oral activated charcoal, Clinical Pharmacology and Therapeutics, 33, pp. 351-354, (1983)
[5]  
Brent J., Kulig K., Rumack B.H., Iatrogenic death from sorbitol and magnesium sulfate during treatment for salicylism, Veterinary and Human Toxicology, 31, (1989)
[6]  
Caldwell J.W., Nava A.J., De Haas D.D., Hypernatremia associated with cathartics in overdose management, Western Journal of Medicine, 147, (1987)
[7]  
Cooney D.O., Activated charcoal, Antidotal and other medicinal uses, (1980)
[8]  
Curtis R.A., Barone J., Giacona N., Efficacy of ipecac and activated charcoal/cathartic: prevention of salicylate absorption in a simulated overdose, Archives of Internal Medicine, 144, pp. 48-52, (1984)
[9]  
Deriet R.W., Albertson T.E., Activated charcoal — past, present and future, Western Journal of Medicine, 145, pp. 493-496, (1986)
[10]  
Easom J.M., Caraccio T.R., Lovejoy F.H., Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans, Clinical Pharmacy, 1, pp. 154-156, (1982)